CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells
Arias Cardenas, Kelly C, Enos, Clinton W, Spear, Mark R, Austin, Dana E, Almofeez, Raghad, Kortchak, Stephanie, Pincus, Lauren, Guo, Hua-Bei, Dolezal, Samuel, Pierce, J Michael, Furth, Emma, Gineste, Cyrille, Kwon, Yongjun, Gelber, Cohava
Published in Current cancer drug targets (01.01.2024)
Published in Current cancer drug targets (01.01.2024)
Get more information
Journal Article